Indonesia, the largest country in Southeast Asia by population and economy, is considered a key market in the regional healthcare sector. Daewoong Pharmaceutical announced on June 9 that it has signed a memorandum of understanding (MOU) with the Indonesian Pharmacists Association (IAI).
The agreement aims to establish a collaborative foundation to enhance the expertise of local pharmacists and improve public health. The two parties plan to work together in areas including pharmacist education and professional development, academic and expert collaboration, public health and disease management, and the localization of pharmaceuticals and healthcare model development.
Daewoong Pharmaceutical and the Indonesian Pharmacists Association will implement tailored education programs for local pharmacists. They will provide lectures focused on pharmaceutical trends and disease management through online webinars and offline symposiums.
Additionally, they will jointly operate a pharmacist expert council to promote product planning and brand consulting that reflects consumer characteristics. This initiative aims to strengthen the localization of key products such as EasyDerm, Impactamin, and EasyN6.
Based on this collaboration, Daewoong Pharmaceutical intends to enhance consumer trust in Indonesia and expand its over-the-counter drug market by 2030. Indonesia is a country that global pharmaceutical companies prioritize when considering entry into Southeast Asia, which is expected to strengthen Daewoong Pharmaceutical's regional business expansion.
Park Eun-kyung, Head of Daewoong Pharmaceutical's CH Marketing Division, stated, "This will be an important starting point for establishing a long-term partnership for the advancement of public health and the improvement of national health. We will actively cooperate to ensure that the pharmacist communities in both countries can establish a sustainable growth foundation."
* This article has been translated by AI.
Copyright ⓒ Aju Press All rights reserved.